Construction of phenoxazine rings containing nitro and sulfonic acid groups leading to phenoxazine-3-sulfonamide derivatives: their evaluation as novel and potential insulin secretagogues

Construction of phenoxazine rings containing nitro and sulfonic acid groups leading to phenoxazine-3-sulfonamide derivatives: their evaluation as novel and potential insulin secretagogues Chemistry and hypoglycemic activity of N-[[(dialkylamino)alkoxy]phenyl]benzamidines Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidines Antihyperglycemic N-Sulfonyl-1a,2,6,6a-tetrahydro-1H,4H-[1,3]dioxepino[5,6-b]azirines: Synthesis, X-ray Structure Analysis, Conformational Behavior, Quantitative Stroposcopic Pulse Radiolysis, and Quantitative Structure-Activity Relationships Insulin-releasing activity of a series of phenylalanine derivatives Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamides Preparation and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles Novel sulfonyl(thio)urea derivatives act efficiently both as insulin secretagogues and as insulinomimetic compounds Sulfonyliminoimidazolidines. A new class of oral hypoglycemic agents. 1. 1-[[p-[2-(Acylamino)ethyl]phenyl]sulfonyl]-2-iminoimidazolidines Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones